Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Gentilini

Showing results (1-10 of 179) with videos related to

Pageof 18
Sort By:
Journal of Molecular Endocrinology|November 27, 2012
The endocannabinoid pathway and the female reproductive organsAnna Maria Di Blasio, Michele Vignali, Davide Gentilini
Molecular and Cellular Endocrinology|July 11, 2006
Deregulated human glioma cell motility: inhibitory effect of somatostatinMaria Grazia Cattaneo, Davide Gentilini, Lucia Maria Vicentini
Cancers|August 26, 2023
Notch, SUMOylation, and ESR-Mediated Signalling Are the Main Molecular Pathways Showing Significantly Different Epimutation Scores between Expressing or Not Oestrogen Receptor Breast Cancer in Three Public EWAS DatasetsLuigi Corsaro, Davide Gentilini, Luciano Calzari, et al.
European Journal of Endocrinology|June 9, 2018
GENETICS IN ENDOCRINOLOGY: Genetic diagnosis of endocrine diseases by NGS: novel scenarios and unpredictable results and risksLuca Persani, Tiziana de Filippis, Carla Colombo, et al.
Cancers|June 19, 2024
Correction: Corsaro et al. Notch, SUMOylation, and ESR-Mediated Signalling Are the Main Molecular Pathways Showing Significantly Different Epimutation Scores between Expressing or Not Oestrogen Receptor Breast Cancer in Three Public EWAS Datasets. <i>Cancers</i> <b>2023</b>, <i>15</i>, 4109Luigi Corsaro, Davide Gentilini, Luciano Calzari, et al.
Gynecologic and Obstetric Investigation|March 20, 2014
A rare familial case of endometriosis with very severe gynecological and obstetric complications: novel genetic variants at a glanceLaura Buggio, Luca Pagliardini, Davide Gentilini, et al.
Annals of Clinical and Translational Neurology|June 27, 2025
Timing and Predictive Value of Clinical Conditions Preceding Multiple Sclerosis in the UK BiobankAndrea Nova, Teresa Fazia, Giovanni Di Caprio, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 9, 2024
Exploring the complexities of epigenetics in multiple sclerosis: A study involving meta-analysis of DNA methylation profiles, epigenetic drift, and rare epivariationsGiulia Nicole Baldrighi, Rebecca Cavagnola, Davide Sacco, et al.
Gut|September 21, 2011
Visceral adipocytes: old actors in obesity and new protagonists in Crohn's disease?Alessandra Zulian, Raffaella Cancello, Giancarlo Micheletto, et al.
Fertility and Sterility|February 19, 2008
Progesterone receptor +331G/A polymorphism in endometriosis and deep-infiltrating endometriosisDavide Gentilini, Paola Vigano, Luca Carmignani, et al.
Pageof 18

Showing results (1-10 of 179) with videos related to

Sort By:
Pageof 18
Journal of Molecular Endocrinology|November 27, 2012
The endocannabinoid pathway and the female reproductive organsAnna Maria Di Blasio, Michele Vignali, Davide Gentilini
Molecular and Cellular Endocrinology|July 11, 2006
Deregulated human glioma cell motility: inhibitory effect of somatostatinMaria Grazia Cattaneo, Davide Gentilini, Lucia Maria Vicentini
Cancers|August 26, 2023
Notch, SUMOylation, and ESR-Mediated Signalling Are the Main Molecular Pathways Showing Significantly Different Epimutation Scores between Expressing or Not Oestrogen Receptor Breast Cancer in Three Public EWAS DatasetsLuigi Corsaro, Davide Gentilini, Luciano Calzari, et al.
European Journal of Endocrinology|June 9, 2018
GENETICS IN ENDOCRINOLOGY: Genetic diagnosis of endocrine diseases by NGS: novel scenarios and unpredictable results and risksLuca Persani, Tiziana de Filippis, Carla Colombo, et al.
Cancers|June 19, 2024
Correction: Corsaro et al. Notch, SUMOylation, and ESR-Mediated Signalling Are the Main Molecular Pathways Showing Significantly Different Epimutation Scores between Expressing or Not Oestrogen Receptor Breast Cancer in Three Public EWAS Datasets. <i>Cancers</i> <b>2023</b>, <i>15</i>, 4109Luigi Corsaro, Davide Gentilini, Luciano Calzari, et al.
Gynecologic and Obstetric Investigation|March 20, 2014
A rare familial case of endometriosis with very severe gynecological and obstetric complications: novel genetic variants at a glanceLaura Buggio, Luca Pagliardini, Davide Gentilini, et al.
Annals of Clinical and Translational Neurology|June 27, 2025
Timing and Predictive Value of Clinical Conditions Preceding Multiple Sclerosis in the UK BiobankAndrea Nova, Teresa Fazia, Giovanni Di Caprio, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 9, 2024
Exploring the complexities of epigenetics in multiple sclerosis: A study involving meta-analysis of DNA methylation profiles, epigenetic drift, and rare epivariationsGiulia Nicole Baldrighi, Rebecca Cavagnola, Davide Sacco, et al.
Gut|September 21, 2011
Visceral adipocytes: old actors in obesity and new protagonists in Crohn's disease?Alessandra Zulian, Raffaella Cancello, Giancarlo Micheletto, et al.
Fertility and Sterility|February 19, 2008
Progesterone receptor +331G/A polymorphism in endometriosis and deep-infiltrating endometriosisDavide Gentilini, Paola Vigano, Luca Carmignani, et al.
Pageof 18